We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.23B
AUM Growth
+$1.6B
Cap. Flow
+$897M
Cap. Flow %
21.18%
Top 10 Hldgs %
21.32%
Holding
1,176
New
232
Increased
605
Reduced
167
Closed
168

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$84.9M
2
LU icon
Lufax Holding
LU
+$59.6M
3
BABA icon
Alibaba
BABA
+$42.6M
4
JD icon
JD.com
JD
+$41.5M
5
GRPN icon
Groupon
GRPN
+$36.4M

Top Sells

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$25.2M
2
JMIA
Jumia Technologies
JMIA
+$21.7M
3
MTCH icon
Match Group
MTCH
+$20.5M
4
FVRR icon
Fiverr
FVRR
+$15.4M
5
SFIX
Stitch Fix
SFIX
+$10.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.91%
2 Technology 23.48%
3 Communication Services 13.86%
4 Financials 4.63%
5 Real Estate 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXMD icon
951
TherapeuticsMD
TXMD
$24M
$8K ﹤0.01%
141
+94
+200% +$6.42K
VSTM icon
952
Verastem
VSTM
$610M
$8K ﹤0.01%
+325
New +$6.53K
WVE icon
953
Wave Life Sciences
WVE
$1.2B
$8K ﹤0.01%
1,120
+810
+261% +$6.8K
MRNS
954
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$8K ﹤0.01%
+700
New +$9.76K
SURF
955
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$8K ﹤0.01%
+965
New +$8.39K
TCDA
956
DELISTED
Tricida, Inc. Common Stock
TCDA
$8K ﹤0.01%
1,165
+737
+172% +$5.65K
AUTL
957
Autolus Therapeutics
AUTL
$562M
$7K ﹤0.01%
795
+511
+180% +$5.45K
FULC icon
958
Fulcrum Therapeutics
FULC
$297M
$7K ﹤0.01%
+630
New +$7.12K
IMUX icon
959
Immunic
IMUX
$195M
$7K ﹤0.01%
+48
New +$8.62K
KALV
960
DELISTED
KalVista Pharmaceuticals
KALV
$7K ﹤0.01%
+410
New +$7.03K
LRMR icon
961
Larimar Therapeutics
LRMR
$432M
$7K ﹤0.01%
+355
New +$7.11K
RNAC icon
962
Cartesian Therapeutics
RNAC
$268M
$7K ﹤0.01%
+83
New +$7.2K
CALA
963
DELISTED
Calithera Biosciences, Inc
CALA
$7K ﹤0.01%
+81
New +$7.1K
KLDO
964
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$7K ﹤0.01%
+850
New +$6.97K
GSKY
965
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$7K ﹤0.01%
1,643
-1,503
-48% -$6.8K
ABUS icon
966
Arbutus Biopharma
ABUS
$915M
$6K ﹤0.01%
+1,950
New +$6.83K
ACET icon
967
Adicet Bio
ACET
$74.7M
$6K ﹤0.01%
28
+25
+833% +$5.12K
C icon
968
Citigroup
C
$226B
$6K ﹤0.01%
+111
New +$5.64K
CABA icon
969
Cabaletta Bio
CABA
$455M
$6K ﹤0.01%
+550
New +$7.13K
CTMX icon
970
CytomX Therapeutics
CTMX
$754M
$6K ﹤0.01%
1,060
+666
+169% +$4.76K
FCFS icon
971
FirstCash
FCFS
$8.78B
$6K ﹤0.01%
87
+19
+28% +$1.2K
KMDA icon
972
Kamada
KMDA
$419M
$6K ﹤0.01%
+1,070
New +$7.61K
NXTC icon
973
NextCure
NXTC
$26.7M
$6K ﹤0.01%
+53
New +$6.85K
RDHL
974
Redhill Biopharma
RDHL
$3.68M
$6K ﹤0.01%
+1
New +$8.99K
TD icon
975
Toronto Dominion Bank
TD
$200B
$6K ﹤0.01%
+121
New +$6.13K
37 38
39
40 41

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Penserra Capital Management held 1,176 positions worth $4.23B, up 61% from $2.63B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Penserra Capital Management deployed $897M of net new capital in Q4 2020, opening 232 new positions and adding to 605 existing holdings. Its largest new stake was KE Holdings: 1,278,021 shares worth $78.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Peloton Interactive, an estimated $25.2M trimmed.

  • Penserra Capital Management's largest Q4 2020 buy was KE Holdings: 1,278,021 shares worth $78.6M.
  • Penserra Capital Management added most to Alibaba in Q4 2020, an estimated $42.6M increase.
  • Penserra Capital Management's biggest Q4 2020 reduction was Peloton Interactive, cutting an estimated $25.2M.
  • Penserra Capital Management fully exited Palomar in Q4 2020, selling an estimated $6.65M.
  • Penserra Capital Management's ten largest holdings make up 21% of its $4.23B portfolio in Q4 2020.
  • Penserra Capital Management opened 232 new positions and closed 168 in Q4 2020.
  • Penserra Capital Management's portfolio value rose 61% quarter-over-quarter to $4.23B.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.